RELX Plc (RLXXF)
London, GB
RELX PLC delivers advanced data-driven analytical insights and strategic decision-making instruments to a diverse global customer base, encompassing professional and commercial enterprises across North America, Europe, and other international regions. The company's operations are divided into four primary divisions: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. Its Risk segment provides sophisticated analytical and evaluative tools. These tools integrate a wealth of public and industry-specific content with cutting-edge technology and algorithms, enabling clients to effectively assess and anticipate potential dangers. The Scientific, Technical & Medical division furnishes critical information and analytical capabilities, empowering institutions and professionals to drive scientific advancements and improve healthcare outcomes. Through its Legal arm, RELX offers vital legal, regulatory, and business intelligence, alongside analytical services, designed to support informed decision-making and enhance productivity for its clientele. Finally, the Exhibitions segment orchestrates events that expertly blend in-person interactions with digital technologies and data resources, allowing participants to explore market trends, identify suppliers, and finalize transactions. Established in 1903 and headquartered in London, United Kingdom, the organization was previously known as Reed Elsevier PLC, adopting its current name, RELX PLC, in July 2015.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.95% | -3.21% | -12.20% | -6.62% | -20.03% | -19.73% | -40.68% | +4.22% | +21.28% | +74.64% | +303.86% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Specialty Business Services: +7.6%+1.6% Q4'25: +4.0% (vs Q4'23)
-
EPS growth Specialty Business Services: +24.4%+8.7% Q4'25: +22.9% (vs Q4'23)
-
FCF margin FCF growth · Specialty Business Services: +27.6%+28.6% ★ Q4'25: +29.8% (vs Q4'23)
-
EBIT margin Specialty Business Services: +9.0%+31.8% ★ Q4'25: +31.9% (vs Q4'23)
-
ROIC Specialty Business Services: +7.8%+24.0% ★ Q4'25: +48.3% (vs Q4'23)
-
Share dilution Specialty Business Services: +0.4%-1.8% ★ Q4'25: -3.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Specialty Business Services: -0.21×1.93× Q4'25: 0.96× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 1 EPS Ana. |
Dec 2027 14 Rev. Ana. 1 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
Dec 2029 9 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.97B
est: 8.89B (-32.9%)
|
6.90B
est: 8.39B (-17.8%)
|
7.36B
est: 10.08B (-27.0%)
|
7.49B
est: 9.66B (-22.4%)
|
7.87B
est: 10.49B (-25.0%)
|
7.11B
est: 9.83B (-27.6%)
|
7.24B
est: 9.88B (-26.6%)
|
8.55B
est: 10.22B (-16.3%)
|
9.16B
est: 11.71B (-21.8%)
|
9.43B
est: 9.55B (-1.2%)
|
9.59B
est: 9.63B (-0.5%)
|
10.09B
9.78B – 10.33B
+4.8% YoY
|
10.71B
10.46B – 10.97B
+6.1% YoY
|
11.52B
11.21B – 11.80B
+7.6% YoY
|
12.55B
12.21B – 12.85B
+8.9% YoY
|
| EBITDA |
2.02B
est: 3.11B (-35.1%)
|
2.32B
est: 2.94B (-21.2%)
|
2.49B
est: 3.53B (-29.3%)
|
2.62B
est: 3.38B (-22.5%)
|
2.73B
est: 3.67B (-25.7%)
|
2.48B
est: 3.44B (-28.0%)
|
2.65B
est: 3.46B (-23.4%)
|
3.01B
est: 3.58B (-15.9%)
|
3.31B
est: 4.10B (-19.2%)
|
3.05B
est: 3.94B (-22.7%)
|
3.80B
est: 3.98B (-4.5%)
|
4.17B
4.04B – 4.27B
+4.8% YoY
|
4.42B
4.32B – 4.53B
+6.1% YoY
|
4.76B
4.63B – 4.87B
+7.6% YoY
|
5.18B
5.05B – 5.31B
+8.9% YoY
|
| EBIT |
1.41B
est: 2.39B (-41.0%)
|
1.66B
est: 2.26B (-26.6%)
|
1.85B
est: 2.71B (-31.7%)
|
1.92B
est: 2.60B (-26.0%)
|
2.05B
est: 2.82B (-27.5%)
|
1.63B
est: 2.64B (-38.2%)
|
1.92B
est: 2.66B (-27.7%)
|
2.30B
est: 2.75B (-16.6%)
|
2.60B
est: 3.15B (-17.6%)
|
2.82B
est: 3.63B (-22.3%)
|
3.05B
est: 3.66B (-16.7%)
|
3.83B
3.71B – 3.92B
+4.8% YoY
|
4.07B
3.97B – 4.17B
+6.1% YoY
|
4.38B
4.26B – 4.48B
+7.6% YoY
|
4.77B
4.64B – 4.88B
+8.9% YoY
|
| Net Income |
1.01B
est: 1.14B (-11.7%)
|
1.16B
est: 1.34B (-13.6%)
|
1.66B
est: 1.55B (+7.2%)
|
1.42B
est: 1.51B (-5.7%)
|
1.51B
est: 1.79B (-15.9%)
|
1.22B
est: 1.53B (-19.8%)
|
1.47B
est: 1.64B (-10.3%)
|
1.63B
est: 1.89B (-13.4%)
|
1.78B
est: 2.13B (-16.2%)
|
1.93B
est: 2.23B (-13.2%)
|
2.06B
est: 2.36B (-12.5%)
|
2.60B
2.51B – 2.68B
+10.1% YoY
|
2.88B
2.78B – 2.97B
+10.6% YoY
|
3.24B
3.13B – 3.34B
+12.6% YoY
|
3.65B
3.53B – 3.77B
+12.8% YoY
|
| SGA |
2.41B
est: 3.41B (-29.3%)
|
2.74B
est: 3.21B (-14.9%)
|
2.86B
est: 3.86B (-26.0%)
|
2.92B
est: 3.70B (-21.2%)
|
3.06B
est: 4.02B (-23.9%)
|
3.11B
est: 3.76B (-17.3%)
|
2.83B
est: 3.78B (-25.3%)
|
3.20B
est: 3.92B (-18.2%)
|
3.31B
est: 4.48B (-26.2%)
|
3.32B
est: 3.44B (-3.7%)
|
3.13B
est: 3.47B (-10.1%)
|
3.64B
3.53B – 3.72B
+4.8% YoY
|
3.86B
3.77B – 3.96B
+6.1% YoY
|
4.15B
4.04B – 4.26B
+7.6% YoY
|
4.53B
4.41B – 4.64B
+8.9% YoY
|
| EPS |
0.46
est: 0.61 (-24.3%)
|
0.56
est: 0.72 (-21.8%)
|
0.82
est: 0.82 (-0.6%)
|
0.72
est: 0.80 (-10.3%)
|
0.77
est: 0.95 (-19.2%)
|
0.64
est: 0.81 (-21.3%)
|
0.76
est: 0.87 (-13.1%)
|
0.85
est: 1.01 (-15.5%)
|
0.94
est: 1.13 (-17.0%)
|
1.04
est: 1.21 (-13.9%)
|
1.13
est: 1.28 (-11.8%)
|
1.41
1.36 – 1.45
+10.1% YoY
|
1.56
1.51 – 1.61
+10.6% YoY
|
1.76
1.70 – 1.81
+12.6% YoY
|
1.98
1.91 – 2.04
+12.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Erik Engstrom | Chief Executive Officer & Executive Director | 5M | male |
| Nicholas Lawrence Luff | Chief Financial Officer & Executive Director | 3M | male |
| Bianca Elisabeth Maria Tetteroo | Workforce Engagement Director & Independent Non-Executive Director | 170.7K | female |
| Mark Kelsey | Chief Executive Officer of Risk | — | male |
| Michael Walsh | Chief Executive Officer of Legal | — | male |
| Paul Abrahams | Head of Corporation Communications | — | male |
| Paul Daniel Alexander Sullivan | Head of Investor Relations | — | male |
| Rosemary Thomson | Chief Human Resources Officer | — | female |
| Henry Adam Udow | Chief Legal Officer & Company Secretary | — | male |
| Marcia Balisciano | Chief Sustainability Officer & Global Head of Corporate Responsibility | — | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RLXXF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
